Tissue Donors
6
1
1
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
16.7%
1 terminated out of 6 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy
Prone vs Supine Position in Potential Organ Donors: Multicenter Clinical Trial
Peri-implant Tissue Stability Following Tissue Augmentation Harvested From Deep Palate or Tuberosity
The Effect of Remote Ischemic Preconditioning in Living Donor Hepatectomy
Evaluation of Post-traumatic Stress Among the Nearest Relatives of Brain-dead Organ Donors
RELIVE Informed Consent Study